MARIA MILJUTINA: Open Payments
NPI 1508458704 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 23 payments from 8 companies in 2025. Trend: 2023 $43 · 2024 $132 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 8 | $131 |
| Ardelyx, Inc. | 5 | $98 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $71 |
| ABBVIE INC. | 2 | $37 |
| Janssen Biotech, Inc. | 1 | $26 |
| QOL Medical, LLC | 1 | $20 |
| VIVUS LLC | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
Products named: VOQUEZNA, IBSRELA, XIFAXAN, TREMFYA, Sucraid, MAVYRET, QSYMIA, LINZESS.
Industry payments across NJ — which companies pay providers there.
